iframe {
border: 1px solid #e4e5e6;
}
.pull-right.blog-single{
float:none !important
}

CEO Mark Capone describes the Myriad Vision and what it means to us. “We want to be the trusted advisor transforming patients lives with our pioneering molecular diagnostics.”

Investor Day

August 11, 2022